Shandong Xinhua Pharmaceutical subsidiary obtained the registration certificate for ursodeoxycholic acid capsules.
Xinhua Pharmaceutical (000756.SZ) announced that its wholly-owned subsidiary Shandong Zibo Xinda Pharmaceutical Co., Ltd. (referred to as "...")
Shandong Xinhua Pharmaceutical (000756.SZ) announced that its wholly-owned subsidiary Shandong Zibo Xinda Pharmaceutical Co., Ltd. (referred to as "Xinda Pharmaceutical") has received the "Drug Registration Certificate" issued by the National Medical Products Administration for ursodeoxycholic acid capsules. This drug is used to treat gallbladder cholesterol stones (must be stones that can be penetrated by X-rays, and the gallbladder contraction function must be normal); cholestatic liver disease (such as: primary biliary cirrhosis); and bile reflux gastritis.
Related Articles
GREENTOWN MGMT (09979) spent HK$944,200 to repurchase 300,000 shares on September 16th.
Anzheng Fashion Group (603839.SH) plans to concentrate on competitive bidding to reduce its repurchased shares by no more than 1,870,000 shares.
Sichuan Guangan AAA Public (600979.SH) intends to acquire 90% of the equity of Qitai Hengtuo to expand its wind power generation business.
GREENTOWN MGMT (09979) spent HK$944,200 to repurchase 300,000 shares on September 16th.
Anzheng Fashion Group (603839.SH) plans to concentrate on competitive bidding to reduce its repurchased shares by no more than 1,870,000 shares.
Sichuan Guangan AAA Public (600979.SH) intends to acquire 90% of the equity of Qitai Hengtuo to expand its wind power generation business.
